Cooley advised Dutch Bros, and Latham & Watkins advised the underwriters. Dutch Bros Inc. (NYSE: BROS; Dutch Bros) announced the pricing of an underwritten offering of...
Dutch Bros’ $300 Million Class A Common Stock Offering
ImmuneOnco Biopharmaceuticals’ HK$319 Million IPO
Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
Zepto’s $200 Million Series E Financing Round
Cooley advised Zepto on the fundraising. Zepto announced its $200 million Series E financing, which brings its valuation to $1.4 billion. StepStone Group led the financing round,...
Cellares’ $255 Million Series C Funding Round
Cooley advised Cellares on the fundraising. Cellares has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with the...
Genesis Therapeutics’ $200 Million Series B Funding Round
Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments. Genesis Therapeutics announced that it has...
Ramp’s $300 Million Series D Funding Round
Cooley advised Ramp on the fundraising. Ramp announced a $300 million Series D on the back of strong revenue growth, rapidly increasing market share among small...
Definitive Healthcare’s $52 Million Acquisition of Populi
Cooley advised Definitive Healthcare on the deal. Definitive Healthcare (Nasdaq: DH) announced its acquisition of Populi for $52 million in an all-cash transaction. This acquisition furthers Definitive...
Celadon Partners’ $38 Million Acquisition of Senti Bio’s Assets
Morrison Foerster advised Celadon Partners and GeneFab, while Cooley and Goodwin Procter advised Senti Biosciences. Senti Biosciences, Inc. (Nasdaq: SNTI) and Celadon Partners, LLC announced a transaction...
REX – Real Estate Exchange Inc. v. Zillow Inc. et al
Cooley, alongside a team from Quinn Emanuel Urquhart & Sullivan, secured a summary judgment victory for the National Association of Realtors (NAR) in a high-stakes antitrust...
TransMedics Group’s Acquisition of Organ Support and Heart Preservation Transport System Assets from Bridge to Life
Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
Astellas’s $50 Million Investment to Support Poseida’s Commitment to Redefining Cancer Cell Therapy
Cooley LLP advised Poseida Therapeutics on the deal. Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Poseida Therapeutics, Inc. (NASDAQ: PSTX, CEO:...
Vietnam Sunergy Cell Company’s Business Combination with Blue World Acquisition
Cooley acted as U.S. legal advisor to Vietnam Sunergy Cell Company, and Robinson & Cole acted as U.S. legal advisor to Blue World. Vietnam Sunergy Cell...